Lori A. Wood

Association of Cabozantinib Dose Reductions for Toxicity with Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis)

G. Bjarnason, N. Basappa, S. Tanguay, 2024, Clinical Genitourinary Cancer.

Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System

A. Finelli, G. Bjarnason, C. Kollmannsberger, 2023, JCO global oncology.

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.

F. Saad, A. Kapoor, S. Hotte, 2011, Current oncology.